richard kim, md, on the role of braf mutations in treatment of cholangiocarcinoma
Published 5 years ago • 46 plays • Length 0:43
Download video MP4
Download video MP3
Similar videos
-
1:16
richard kim, md, regarding targeted therapies in treatment of cholangiocarcinoma
-
1:14
richard kim, md, regarding the use of regorafenib in treatment of colorectal cancer
-
2:16
dr. kim on treatment for braf-mutant colon cancer
-
19:03
ac21 - richard kim: which cholangiocarcinoma patients benefit from immunotherapy?
-
1:34
richard kim, md, on the use and sequencing of tkis in hepatocellular carcinoma (hcc)
-
0:49
richard kim, md, considers the effectiveness of combination sorafenib and tace in hcc patients
-
1:18
dr. richard kim on administering aflibercept in colorectal cancer
-
1:17
richard kim, md, shares how we can utilize tkis in the management of hepatocellular carcinoma
-
0:47
rachna shroff, md, discusses how braf mutations figure into cholangiocarcinoma treatment
-
1:14
richard kim, md, discusses pembrolizumab as an effective agent in hcc management
-
1:26
richard kim, md, offers opinion on the redos study and dose escalation of regorafenib
-
1:34
richard kim, md, on results of phase 1 study regarding locally advanced rectal adenocarcioma
-
4:46
finding the faulty braf gene - cancer research uk
-
0:50
richard stone, md, describes the landscape of mutations and targeted therapy in aml
-
1:24
rachna shroff, md, expands on targeted therapies in the treatment of cholangiocarcinoma
-
20:34
role of circulating tumor cells/dna & liquid biopsy in melanoma - david polsky
-
1:34
dr. kim discusses cytoreductive nephrectomy in metastatic rcc
-
1:20
richard goldberg, md, fasco, shares his impression of the adjuvant biliary tract study at asco 2017
-
1:28
dr. gordan on molecular diagnostics in biliary tract cancers
Clip.africa.com - Privacy-policy